In AD, scRNA-seq has identified disease-associated microglia (DAM), a subpopulation of immune cells characterized by upregulated expression of Trem2, ApoE, and inflammatory cytokines, highlighting their dual role in promoting neuroinflammation and clearing amyloid plaques [71,72]. The gene discussed is TREM2; the disease is Alzheimer disease.